Global Orally Administered Vaccine Market Research Report 2024(Status and Outlook)

Global Orally Administered Vaccine Market Research Report 2024(Status and Outlook)



Report Overview:

Orally administered vaccines are of interest, as they elicit both systemic and mucosal immunities, in which mucosal immunity would neutralize the mucosa invading pathogen before the onset of an infection.

The Global Orally Administered Vaccine Market Size was estimated at USD 2692.07 million in 2023 and is projected to reach USD 3754.37 million by 2029, exhibiting a CAGR of 5.70% during the forecast period.

This report provides a deep insight into the global Orally Administered Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Orally Administered Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Orally Administered Vaccine market in any manner.

Global Orally Administered Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck

GSK

Sanofi

Lanzhou Institute

Serum Institute

Valneva

Shanghai United Cell

Bibcol

PaxVax

Vabiotech

Tiantan Biological

EuBiologics

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Market Segmentation (by Type)

Rotavirus Vaccine

Cholera Vaccine

Oral Polio Vaccine

Other

Market Segmentation (by Application)

Public

Private

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Orally Administered Vaccine Market

Overview of the regional outlook of the Orally Administered Vaccine Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Orally Administered Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Orally Administered Vaccine
1.2 Key Market Segments
1.2.1 Orally Administered Vaccine Segment by Type
1.2.2 Orally Administered Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Orally Administered Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Orally Administered Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Orally Administered Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Orally Administered Vaccine Market Competitive Landscape
3.1 Global Orally Administered Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Orally Administered Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Orally Administered Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Orally Administered Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Orally Administered Vaccine Sales Sites, Area Served, Product Type
3.6 Orally Administered Vaccine Market Competitive Situation and Trends
3.6.1 Orally Administered Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Orally Administered Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Orally Administered Vaccine Industry Chain Analysis
4.1 Orally Administered Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Orally Administered Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Orally Administered Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Orally Administered Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Orally Administered Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Orally Administered Vaccine Price by Type (2019-2024)
7 Orally Administered Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Orally Administered Vaccine Market Sales by Application (2019-2024)
7.3 Global Orally Administered Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Orally Administered Vaccine Sales Growth Rate by Application (2019-2024)
8 Orally Administered Vaccine Market Segmentation by Region
8.1 Global Orally Administered Vaccine Sales by Region
8.1.1 Global Orally Administered Vaccine Sales by Region
8.1.2 Global Orally Administered Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Orally Administered Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Orally Administered Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Orally Administered Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Orally Administered Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Orally Administered Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck Orally Administered Vaccine Basic Information
9.1.2 Merck Orally Administered Vaccine Product Overview
9.1.3 Merck Orally Administered Vaccine Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Orally Administered Vaccine SWOT Analysis
9.1.6 Merck Recent Developments
9.2 GSK
9.2.1 GSK Orally Administered Vaccine Basic Information
9.2.2 GSK Orally Administered Vaccine Product Overview
9.2.3 GSK Orally Administered Vaccine Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Orally Administered Vaccine SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi
9.3.1 Sanofi Orally Administered Vaccine Basic Information
9.3.2 Sanofi Orally Administered Vaccine Product Overview
9.3.3 Sanofi Orally Administered Vaccine Product Market Performance
9.3.4 Sanofi Orally Administered Vaccine SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Lanzhou Institute
9.4.1 Lanzhou Institute Orally Administered Vaccine Basic Information
9.4.2 Lanzhou Institute Orally Administered Vaccine Product Overview
9.4.3 Lanzhou Institute Orally Administered Vaccine Product Market Performance
9.4.4 Lanzhou Institute Business Overview
9.4.5 Lanzhou Institute Recent Developments
9.5 Serum Institute
9.5.1 Serum Institute Orally Administered Vaccine Basic Information
9.5.2 Serum Institute Orally Administered Vaccine Product Overview
9.5.3 Serum Institute Orally Administered Vaccine Product Market Performance
9.5.4 Serum Institute Business Overview
9.5.5 Serum Institute Recent Developments
9.6 Valneva
9.6.1 Valneva Orally Administered Vaccine Basic Information
9.6.2 Valneva Orally Administered Vaccine Product Overview
9.6.3 Valneva Orally Administered Vaccine Product Market Performance
9.6.4 Valneva Business Overview
9.6.5 Valneva Recent Developments
9.7 Shanghai United Cell
9.7.1 Shanghai United Cell Orally Administered Vaccine Basic Information
9.7.2 Shanghai United Cell Orally Administered Vaccine Product Overview
9.7.3 Shanghai United Cell Orally Administered Vaccine Product Market Performance
9.7.4 Shanghai United Cell Business Overview
9.7.5 Shanghai United Cell Recent Developments
9.8 Bibcol
9.8.1 Bibcol Orally Administered Vaccine Basic Information
9.8.2 Bibcol Orally Administered Vaccine Product Overview
9.8.3 Bibcol Orally Administered Vaccine Product Market Performance
9.8.4 Bibcol Business Overview
9.8.5 Bibcol Recent Developments
9.9 PaxVax
9.9.1 PaxVax Orally Administered Vaccine Basic Information
9.9.2 PaxVax Orally Administered Vaccine Product Overview
9.9.3 PaxVax Orally Administered Vaccine Product Market Performance
9.9.4 PaxVax Business Overview
9.9.5 PaxVax Recent Developments
9.10 Vabiotech
9.10.1 Vabiotech Orally Administered Vaccine Basic Information
9.10.2 Vabiotech Orally Administered Vaccine Product Overview
9.10.3 Vabiotech Orally Administered Vaccine Product Market Performance
9.10.4 Vabiotech Business Overview
9.10.5 Vabiotech Recent Developments
9.11 Tiantan Biological
9.11.1 Tiantan Biological Orally Administered Vaccine Basic Information
9.11.2 Tiantan Biological Orally Administered Vaccine Product Overview
9.11.3 Tiantan Biological Orally Administered Vaccine Product Market Performance
9.11.4 Tiantan Biological Business Overview
9.11.5 Tiantan Biological Recent Developments
9.12 EuBiologics
9.12.1 EuBiologics Orally Administered Vaccine Basic Information
9.12.2 EuBiologics Orally Administered Vaccine Product Overview
9.12.3 EuBiologics Orally Administered Vaccine Product Market Performance
9.12.4 EuBiologics Business Overview
9.12.5 EuBiologics Recent Developments
9.13 Panacea Biotec Ltd
9.13.1 Panacea Biotec Ltd Orally Administered Vaccine Basic Information
9.13.2 Panacea Biotec Ltd Orally Administered Vaccine Product Overview
9.13.3 Panacea Biotec Ltd Orally Administered Vaccine Product Market Performance
9.13.4 Panacea Biotec Ltd Business Overview
9.13.5 Panacea Biotec Ltd Recent Developments
9.14 Bio-Med
9.14.1 Bio-Med Orally Administered Vaccine Basic Information
9.14.2 Bio-Med Orally Administered Vaccine Product Overview
9.14.3 Bio-Med Orally Administered Vaccine Product Market Performance
9.14.4 Bio-Med Business Overview
9.14.5 Bio-Med Recent Developments
9.15 Halfkin Bio-Pharmaceuticals
9.15.1 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Basic Information
9.15.2 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Overview
9.15.3 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Market Performance
9.15.4 Halfkin Bio-Pharmaceuticals Business Overview
9.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
10 Orally Administered Vaccine Market Forecast by Region
10.1 Global Orally Administered Vaccine Market Size Forecast
10.2 Global Orally Administered Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Orally Administered Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Orally Administered Vaccine Market Size Forecast by Region
10.2.4 South America Orally Administered Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Orally Administered Vaccine by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Orally Administered Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Orally Administered Vaccine by Type (2025-2030)
11.1.2 Global Orally Administered Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Orally Administered Vaccine by Type (2025-2030)
11.2 Global Orally Administered Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Orally Administered Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Orally Administered Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings